trending Market Intelligence /marketintelligence/en/news-insights/trending/ob8pwmnk3grbw5d2bs2foq2 content esgSubNav
In This List

Verastem Oncology begins $35M common stock offering

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Verastem Oncology begins $35M common stock offering

Verastem Inc. commenced a public offering of its common stock worth $35 million.

The Needham, Mass.-based biopharmaceutical company granted the underwriter an option to buy up to an additional $5.25 million worth of common shares.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.